Private company
Logo: Ketheric Bryan, CC BY-SA 4.0, via Wikimedia Commons3
Regenerative medicine company background
Aroa Biosurgery Limited (formerly Mesynthes Limited) is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange (ASX: ARX).2 From Wikipedia, CC BY-SA 4.0
Last updated Oct 16, 2026.
See how the biggest companies compare on our leaderboards
Aroa Biosurgery Limited (formerly Mesynthes Limited) is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange (ASX: ARX).2
History
2008 – Mesynthes Limited (Wellington, New Zealand) was founded by Brian Ward.
2008 – First patent of ovine forestomach matrix and reinforced biologics.
2009 – Endoform Natural™ cleared by the US FDA for treatment of acute and chronic wounds.
2010 – OFM first described in the scientific literature.
2010 – OFM reinforced biologics first described in scientific literature.
From Wikipedia’s article on Aroa Biosurgery Limited, shared under CC BY-SA 4.0.2
The numbers on this page point here. Each one links to the record it came from.